news

« BACK

LUXEMBOURG


Results 41 - 44 of 44.


Health - Pharmacology - 21.04.2022
The why behind mild COVID-19
All-Luxembourg study helps to anticipate a personal COVID-19 health trajectory From the start of the COVID-19 pandemic, the majority of published studies have focused on severe COVID-19 patients in order to understand the causes of critical illness. However, it is equally, if not more important to understand the protective immune factors in our body.

Health - Pharmacology - 12.04.2022
B or not to B: Insights in the regulation of anti-viral immunity
Researchers delve into the inner workings of the antibody immune response, finding key differences in the metabolism of two closely related immune cell subsets. Protection against viral diseases is a key role of our body's immune response, where antibodies are generated to seek out invading species and either neutralise or mark them for destruction.

Physics - Materials Science - 18.03.2022
Tiny but Mighty: Atomic Forces at the Engineering Scale
An interdisciplinary manuscript reporting on a collaboration between physicists and computational engineers from the University of Luxembourg and Padova (Italy) has been published in Physical Review Letters. This work reveals that interactions between many electrons in materials can induce a colossal enhancement of atomic forces at the nanoscale and in large engineering-scale systems.

Life Sciences - Health - 17.03.2022
Midbrain single-cell sequencing to understand Parkinson’s Disease
Researchers from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, in collaboration with the Max Planck Institute for Molecular Genetics in Berlin, investigated the different cell types present in the human midbrain to better understand their respective role in Parkinson's disease.